Resveratrol Endothelial Function Meta-analysis: What the Evidence Says

Quick Answer

Resveratrol Endothelial Function Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 systematic review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Resveratrol is a naturally occurring polyphenolic compound found in various plants, including grapes, berries, and peanuts. [Meden Ana (2026); evidence level 1]
• However, most available evidence originates from studies focusing on metabolic forms of diabetes rather than pancreatic disease-related diabetes (,-). [Meden Ana (2026); evidence level 1]
• Resveratrol is a polyphenol belonging to the family of stilbenes, predominantly found in grapes and wine. [Sun Jia-Nan (2026); evidence level 1]
• Growing clinical trials have indicated its potential to reduce the risk and progression of various chronic diseases, such as type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), and cognitive disorders. [Sun Jia-Nan (2026); evidence level 1]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For resveratrol endothelial function meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Meden Ana (2026). Resveratrol in diabetes and pancreatic function: implications for the exocrine–endocrine pancreatic axis–a systematic review. DOI: 10.3389/fnut.2026.1806881. PMCID: PMC13144009. PMID: 42099770. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13144009/
• Sun Jia-Nan (2026). Effects of resveratrol supplementation on multiple health outcomes: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials. DOI: 10.1186/s12937-026-01319-5. PMCID: PMC13196030. PMID: 41987155. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13196030/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.